Effective prevention of sorafenib-related vascular damage induced adverse events and maintenance of hepatic function by dried bonito broth and histidine

Background: Sorafenib (SOR) is an anti-angiogenic chemotherapeutic that prolongs the survival rates of patients with hepatocellular carcinoma. However, SOR also damages normal vasculature and causes associated adverse events, including hand–foot syndrome and hypertension (HT). We previously reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Norihiro, Kamimura, Kenya, Shinagawa-Kobayashi, Yoko, Nagoya, Takuro, Niwa, Yusuke, Ko, Masayoshi, Setsu, Toru, Sakamaki, Akira, Yokoo, Takeshi, Abe, Satoshi, Kamimura, Hiroteru, Sugitani, Soichi, Yanagi, Masahiko, Terai, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525960/
https://www.ncbi.nlm.nih.gov/pubmed/31191006
http://dx.doi.org/10.2147/CMAR.S201424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525960/
https://www.ncbi.nlm.nih.gov/pubmed/31191006
http://dx.doi.org/10.2147/CMAR.S201424

Ejemplares similares